| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |